Gerald D. van Eeckhout
Vorsitzender bei EmboMedics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jafar Golzarian | M | - |
EmboMedics, Inc.
 EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 12 Jahre |
| Eric Madson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Robert Halverson | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 9 Jahre |
| Reza Malek | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Lihui Weng | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
| Marc Sapoval | M | - |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Cohen | M | 66 |
EmboMedics, Inc.
EmboMedics, Inc. Medical SpecialtiesHealth Technology EmboMedics, Inc. develops and commercializes resorbable and drug loaded embolization devices. Its products include Transarterial Embolization, Chemoebolization Indications, The firm's devices are helpful in treating aneurisms, epistaxis and uterine fibroids. The company was founded by Jafar Golzarian and Omid Souresrafil in 2012 and is headquartered in Maple Grove, MN. | 2 Jahre |
| Paul Korus | M | 67 |
University of North Dakota
| 6 Jahre |
| Glenn Pomeroy | M | - |
University of North Dakota
| 7 Jahre |
| David S. Finn | M | - |
University of North Dakota
| 4 Jahre |
| Arlen Nordhagen | M | 67 |
University of North Dakota
| 4 Jahre |
| Jan P. Rudolf | M | - |
University of North Dakota
| 4 Jahre |
| Terry Stoa | M | - |
University of North Dakota
| 4 Jahre |
| Robert A. Miller | M | - |
University of North Dakota
| 4 Jahre |
| Joseph P. Peterson | M | - |
University of North Dakota
| 4 Jahre |
| Greg Gunderson | M | - |
University of North Dakota
| 5 Jahre |
| Pamela J. Moret | F | 68 |
University of North Dakota
| 4 Jahre |
| Scott D. Rued | M | 67 |
University of North Dakota
| 4 Jahre |
| Jody Feragen | F | 68 |
University of North Dakota
| 4 Jahre |
| Kevin Lemke | M | 71 |
University of North Dakota
| 4 Jahre |
| Kris E. Compton | F | - |
University of North Dakota
| 4 Jahre |
| Linda Pancratz | F | - |
University of North Dakota
| 3 Jahre |
| Jeffrey P. Vickers | M | 71 |
University of North Dakota
| 4 Jahre |
| Randy Newman | M | 70 |
University of North Dakota
| 4 Jahre |
| David Fennell | M | 70 |
University of North Dakota
| 4 Jahre |
| Craig B. Nelson | M | - |
University of North Dakota
| 4 Jahre |
| Nicholas L. Voller | M | 73 |
University of North Dakota
| 4 Jahre |
| Linda Laskowski | F | - |
University of North Dakota
| 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 28 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gerald D. van Eeckhout
- Persönliches Netzwerk
